A cleaning solution for ex vivo tissues and its application
By combining a cleaning solution containing intracellular extract of Akkermansia muciniphila and bromelain, along with catechins from the American dermatitis plantarum, the problems of biofilm contamination and cell viability damage in the cleaning of isolated gastrointestinal tissues have been solved. This has achieved a highly efficient and time-saving cleaning effect, reducing the contamination rate and the risk of drug resistance.
Patent Information
- Application Number
- CN202611619027.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-10-20
- Publication Date
- 2026-11-17
AI Technical Summary
Existing technologies are insufficient to effectively remove biofilm structures from the surface of isolated gastrointestinal tissues and mucosal crypts, resulting in high contamination rates and damage to cell activity. The cleaning process is cumbersome and time-consuming, and antibiotic treatment can easily lead to the emergence of drug-resistant strains.
A cleaning solution combining intracellular extract of Akkermansia muciniphila and bromelain, along with catechins from the American chamomile, is used. Through a specific enzyme system and the nonionic surfactant MEGA-9, the biomembrane structure is disrupted while cell viability is protected. A cleaning method using a combination of pretreatment solution, first cleaning solution, and second cleaning solution is employed.
It significantly reduced the contamination rate of tissue culture, improved cell viability and cleaning efficiency, reduced antibiotic use, simplified the operation process, and shortened the cleaning time.
Smart Images

Figure CN123108113A_ABST
Abstract
Description
Technical Field
[0001] This invention belongs to the field of biomedical technology, specifically relating to an ex vivo tissue cleaning solution and its application. Background Technology
[0002] As a core experimental platform in modern biomedical research, tissue culture technology has a significant advantage over other research methods in that it enables long-term, continuous tracking and observation of ex vivo tissues. Researchers can directly monitor the morphological and structural evolution of target tissues and their life activities. At the same time, this technology allows for precise human intervention and control of culture conditions, covering multiple dimensions such as physical environmental parameters, chemical factor concentration ratios, and the application of bioactive substances. This provides a highly flexible and controllable research vehicle for systematically exploring the influence mechanisms of various factors on tissue growth, development, and functional maintenance. However, when the research focuses on fresh, ex vivo tissues from the gastrointestinal tract, the aforementioned technical system faces an extremely challenging practical problem: the gastrointestinal mucosa is naturally colonized with a large number and variety of symbiotic flora and opportunistic pathogens. These microorganisms are not simply loosely attached to the mucosal surface, but rather form a biofilm network structure with a certain spatial configuration by secreting extracellular polymers. They also bind tightly to specific receptors on the surface of mucosal epithelial cells at the molecular level with the help of various adhesion factors such as pili and adhesins, thereby invading the intercellular junctions and reaching deep into the folded areas at the base of crypts. This forms a stubborn colonization state with superimposed physical and biological barriers, which is difficult to effectively remove using conventional cleaning methods.
[0003] To address the aforementioned contamination issues, the pretreatment methods commonly used in laboratories can be broadly categorized into three technical approaches. The first approach is a simple mechanical cleaning strategy. The procedure involves cutting up isolated gastrointestinal tissue and placing it in sterile saline solution. Through repeated blowing, hand-cranking, and multiple changes of the cleaning solution, the loose fecal residue and free bacteria on the tissue surface are removed using fluid shear force. This typically requires changing the cleaning solution 3-8 times, with each soaking lasting 3-5 minutes. However, this method only works on loosely attached substances on the tissue surface and has almost no effect on colonizing bacteria that have formed biofilm structures or are embedded in mucosal crypts. The second category involves antibiotic-based antibacterial strategies, which involve adding penicillin, streptomycin, and amphotericin B to physiological saline to form a mixed antibiotic solution. Immersing the tissue in this solution for 5-15 minutes aims to kill free-living bacteria. However, this approach completely lacks components that dissociate the adhesion bonds between bacteria and host cells, and antibiotic molecules are limited by the physical barriers of the biofilm matrix, making it difficult to effectively penetrate deep into crypts. Therefore, its effectiveness in killing embedded bacteria is extremely limited. The third category involves rapid chemical disinfection, but this presents a cytotoxicity dilemma.
[0004] In summary, the inherent structural defects of the three treatment methods can be systematically summarized as follows: First, none of them can effectively dissociate bacterial communities that have formed biofilms and colonized mucosal crypts and interepithelial spaces. The mechanical flushing effect of physiological saline cannot break the molecular adhesion bonds between bacteria and host cells, resulting in a large number of colonizing bacteria remaining in the crypts and becoming a major source of repeated contamination during subsequent culture. Second, the direct consequence of this fundamental defect is that the contamination rate of primary tissue cultures remains high for a long time. The treated gastrointestinal mucosal tissue has a high rate of bacterial and fungal contamination after culture, forcing the disposal of valuable samples, increasing the economic and time costs of experiments, and severely restricting the progress of research. Third, the existing methods constitute an irreconcilable contradiction between sterilization efficacy and tissue viability protection. While extending the action time of alcohol or chlorine-containing disinfectants can reduce the contamination rate to some extent, it comes at the cost of massive epithelial cell apoptosis and mucosal tissue necrosis, ultimately leading to a vicious cycle where the more thorough the cleaning, the worse the cell viability. Fourth, the long-term reliance on antibiotics not only fails to remove dormant bacteria encapsulated within biofilms but also induces the generation and accumulation of drug-resistant strains due to continuous antibiotic selection pressure. Residual dormant bacteria rapidly revive and proliferate after being transferred to an antibiotic-free culture system. Fifth, the aforementioned methods are generally cumbersome and time-consuming. A single complete pretreatment process requires changing the cleaning solution more than five times and takes at least 30 minutes. The efficiency bottleneck is particularly prominent when processing batches of samples, making it difficult to meet the high-throughput experimental needs of modern biomedical research. Existing patent literature and scientific papers mostly focus on cleaning and disinfection processes for endoscopic instruments or preoperative irrigation protocols for the human intestine. There are few dedicated cleaning reagents and supporting processes designed for ex vivo fresh gastrointestinal tissue, with the core principle of actively dissociating bacteria from specific adhesion and colonization between the bacteria and the mucosa. Therefore, there is an urgent need to develop a dedicated cleaning solution and supporting cleaning method that can thoroughly clean ex vivo gastrointestinal tissue to significantly reduce the incidence of subsequent culture contamination, minimize antibiotic dependence, and effectively simplify the cleaning process, thereby providing reliable technical support for in vitro culture research of gastrointestinal tissue. Summary of the Invention
[0005] Technical issues The purpose of this invention is to provide an ex vivo tissue cleaning solution and its application, which solves the problems of high contamination rate after tissue cleaning, easy impact on viable cells during the cleaning process, and cumbersome cleaning steps.
[0006] Application of intracellular extract of *Ackermania pseudomallei* in the preparation of ex vivo tissue washing solution, wherein the intracellular extract is prepared by the following method: Akkermansia myxophilus was transferred and cultured sequentially on BHI and FT media 2–3 times until the OD600 reached 0.7–0.9, at which point the bacteria were harvested. The bacterial culture was then transferred to myxin-FT induction medium and cultured anaerobically. The cells were collected by centrifugation, washed with PBS, resuspended in lysis buffer containing MEGA-9, and sonicated on ice at least 10 times. The supernatant was collected by centrifugation, filtered to remove bacteria, and the supernatant was the intracellular extract, which was aliquoted and stored.
[0007] Preferably, the concentration of MEGA-9 is 20-25 mM.
[0008] MEGA-9, an alkyl glycoamide nonionic surfactant, possesses an amphiphilic molecular structure that may enable it to efficiently intercalate and solubilize lipid components in the Gram-negative bilayer membrane of this bacterium. It preferentially disrupts the outer membrane barrier before acting on the inner membrane, thereby significantly increasing cell permeability. At a working concentration of 20–25 mM, its micelle-forming ability is just above the critical micelle concentration, sufficient to effectively lyse the cell membrane, and this effect may exhibit a clear concentration-dependent characteristic. Furthermore, the alkyl chain length (C9) of MEGA-9 has a more compatible affinity with the hydrophobic region of the AKK bacterium's outer membrane lipopolysaccharide, further facilitating its penetration of the bacterium's unique membrane complex.
[0009] Akkermansia muciniphila, a symbiotic bacterium in the intestinal mucus layer that uses mucin as its sole carbon and nitrogen source, has previously been studied primarily for its intracellular extracts in areas such as improving metabolic diseases, regulating intestinal barrier function, and immune responses. However, there are few reports on the application of this bacterium's intracellular extract in tissue cleaning. The innovation of this invention lies not only in discovering a new use for the extract but also in the specially designed induced enrichment process targeting the bacterium's unique mucin-degrading enzyme system. Through specific culture and extraction conditions, the activity of the mucin-degrading enzyme system in the extract is significantly enriched, thereby endowing it with the unique function of efficiently removing residual mucus and protecting tissue integrity when cleaning isolated tissues.
[0010] Preferably, the BHI culture medium contains 7.5-8.5g of calf brain extract, 8.0-10.0g of calf heart extract, 8.0-12.0g of peptone, 1.0-3.0g of glucose, 4.0-6.0g of sodium chloride, and 2.0-3.0g (g / L) of disodium hydrogen phosphate.
[0011] Preferably, the FT culture medium contains 10.0-20.0 g of tryptone, 2.5-7.5 g of yeast extract, 2.5-7.5 g of anhydrous glucose, 0.25-0.75 g of L-cysteine, 1.0-3.0 g of sodium chloride, 0.3-0.7 g of sodium thioglycolate, and 0.001-0.002 g of resazurin (g / L).
[0012] Preferably, the mucin-FT induction medium contains the above-described FT medium components and 1.0~2.0 g / L porcine gastric mucin.
[0013] Preferably, the lysis buffer further contains 40-60 mM Tris-HCl, 140-160 mM NaCl, 0.75-1.25 mM EDTA, and 0.8-1.2 mM PMSF.
[0014] An ex vivo tissue cleaning solution includes a pretreatment solution, a first cleaning solution, and a second cleaning solution.
[0015] Preferably, the pretreatment solution contains sialidase, α-L-fucosidase, β-galactosidase, and Tween-20.
[0016] More preferably, the sterile PBS buffer contains sialidase at a concentration of 0.02 U / mL to 0.06 U / mL, α-L-fucosidase at a concentration of 0.01 U / mL to 0.05 U / mL, β-galactosidase at a concentration of 0.02 U / mL to 0.05 U / mL, and Tween-20 at a concentration of 0.05% to 0.10%.
[0017] Preferably, the first washing solution is a sterile PBS buffer containing intracellular extract of Akkermansia myxophilus and bromelain, wherein the mass ratio of the intracellular extract to bromelain is 1 to 3:1, and the total content of the two is 0.4 mg / mL to 1.2 mg / mL.
[0018] Adding intracellular extracts of *Ackermania mucinosa* and bromelain to the cleaning solution can improve cleaning efficiency. Mucinous proteins (MUCs) are commonly found in bacteria in the gastrointestinal tract. Their structure consists of a complex outer O-glycoglycan shell and an inner protein-peptide backbone. Conventional single proteases can only cleave proteins and cannot penetrate the dense glycocoat. *Ackermania* is the only naturally occurring bacterium that specifically degrades mucins using them as its sole carbon and nitrogen source. Its genome is fully adapted to mucin-degrading enzymes, including glycosidases, sulfatases, and metalloproteinases. The intracellular extract provides a complete set of degrading enzymes, solving the problem of ordinary enzymes being unable to cleave sugar chains. After the glycans are removed, the DNA, previously encapsulated by sugar, is fully exposed. Combined with DNase I, this efficiently cleaves the DNA, breaking down MUC-DNA cross-links, significantly improving overall cleaning efficiency. Bromelain is a thiol-based plant protease that preferentially cleaves unmodified naked peptide regions. MUC molecules contain both numerous glycosylated regions and unmodified naked peptides; the two enzymes target completely different sites, achieving thorough cleavage of the entire MUC sequence.
[0019] More preferably, the first cleaning solution also contains 10 μM Zn 2+Sterile PBS buffer containing 0.015%–0.03% disodium EDTA (w / v), 0.001%–0.004% dispersin B (w / v), 0.001%–0.003% DNase I (w / v), 0.02% L-glutamine (w / v), and 10 μM Y-27632.
[0020] Zn 2+ There will be some chelation with disodium EDTA, but it will not affect the overall effect.
[0021] Preferably, the second washing solution contains sterile PBS buffer containing catechins, wherein the catechin content is 0.05 mg / mL to 0.1 mg / mL.
[0022] Adding linalool to the original cleaning solution components can achieve low bacterial contamination rate and high cell viability without the addition of antibiotics. The hypothesized mechanism is as follows: Linalool is a naturally derived O-methyl flavonoid compound that can synergistically inhibit bacteria with benzalkonium chloride, reducing its toxicity to tissue cells and improving cell survival rate while ensuring sterility; it exerts an anti-inflammatory effect by inhibiting the NF-κB pathway, reducing tissue inflammatory stress induced by enzymatic digestion and shaking during the cleaning process, and protecting the integrity of the mucosal epithelium; the phenolic hydroxyl groups in its molecular structure endow it with antioxidant capacity, which can remove excess free radicals generated during in vitro operations and reduce oxidative damage; it assists in the disintegration of residual bacterial biofilms and mucus layers, and assists in the final cleaning to remove surface attachments.
[0023] More preferably, the second washing solution is a sterile PBS buffer containing 0.02%~0.05% Tween-80 (v / v), 0.005%~0.01% benzalkonium chloride (w / v), 0.02% L-glutamine (w / v) and 10 μM Y-27632.
[0024] A method for using an ex vivo tissue cleaning solution includes the following steps: (1) Take fresh tissue from the body, remove the mesentery and / or fat under aseptic conditions, cut the tissue wall longitudinally, scrape off the surface dirt with sterile forceps; add sterile PBS, shake and discard the waste liquid; (2) Immerse the tissue after coarse washing completely in the pretreatment solution described above, shake at 37°C, then remove the waste liquid, add sterile PBS and shake for 0.5 to 1 min, then discard the waste liquid; (3) The pretreated tissue is completely immersed in the first cleaning solution described above, and shaken at a low speed at 37°C, and then the waste liquid is removed; (4) The tissue after the first cleaning is completely immersed in the second cleaning solution described above, and the waste liquid is discarded after shaking treatment. The immersion and shaking operation is repeated 3 to 5 times to obtain the cleaned isolated gastrointestinal tissue.
[0025] Preferably, in step (2), the volume ratio of the tissue to the pretreatment liquid is 1:5 to 8, the oscillation speed is 40 r / min to 60 r / min, and the treatment time is 10 to 15 min.
[0026] Preferably, in step (3), the volume ratio of the tissue to the first cleaning solution is 1:3 to 5, the oscillation speed is 50 r / min to 80 r / min, and the processing time is 10 to 20 min.
[0027] Preferably, in step (4), the volume ratio of the tissue to the second cleaning solution is 1:5 to 8, the oscillation speed is 50 r / min to 80 r / min, and the processing time for each treatment is 1 to 2 min.
[0028] The above-described tissue cleaning solution is used in the preparation of reagents or kits for cleaning ex vivo tissues.
[0029] The above-described method of use is applied to the cleaning of isolated tissues, wherein the isolated tissues are selected from gastric, small intestine, colon, rectum, bile duct mucosa or esophageal mucosa.
[0030] Beneficial effects Compared with the prior art, the beneficial effects of the present invention are as follows: the use of alkyl glycoamide nonionic MEGA-9 to extract the intracellular extract of Akkermansia obliterans increases its extraction rate; the addition of Akkermansia obliterans intracellular extract and bromelain to the first washing solution; and the addition of tufted American tea extract to the second washing solution, along with the use of pretreatment solution, first washing solution, and second washing solution for soaking and shaking during washing, results in a shorter time, reduces the contamination rate of subsequent tissue culture, improves experimental efficiency, shortens the research cycle, avoids the use of antibiotics, reduces tissue damage during the washing process, and is time-saving. Attached Figure Description
[0031] The present invention will be further described in detail below with reference to the accompanying drawings.
[0032] Figure 1 This indicates the number of live cells in the tissue after cleaning; Figure 2 Indicates the survival rate of tissue cells after cleaning; Figure 3 This indicates the contamination rate of tissue culture after cleaning. Detailed Implementation
[0033] The present invention will be further described in detail below through specific embodiments. Unless otherwise specified, the raw materials, reagents, or apparatus used in the embodiments and comparative examples are all available from conventional commercial sources or can be obtained by existing technical methods. Unless otherwise specified, the test or experimental methods are conventional methods in the art.
[0034] The present invention is described in detail below. Table 1 - Chinese meanings of English abbreviations
[0035] Example 1: Provides methods for culturing and inducing Akkermansia myxophilus: Remove the frozen tubes of *Akkermansia muciniphila* from the anaerobic work station and thaw briefly at room temperature, minimizing air contact throughout. Inoculate 5% (v / v) into pre-reduced BHI medium (7.7g calf brain extract, 9.8g calf heart extract, 10g peptone, 2g glucose, 5g sodium chloride, 2.5g disodium hydrogen phosphate per L). Incubate at 37°C for 40 hours in a constant anaerobic environment (90% N2 + 5% CO2 + 5% H2). Primary growth is slow; control OD600 to 0.4–0.7. Take the revived bacterial culture and inoculate 4% (v / v) onto FT medium, then incubate anaerobicly at 37°C for 24 hours. The culture medium was subcultured again at a 4% (v / v) inoculum in FT medium (15.0 g tryptone, 5.5 g yeast extract, 5.5 g anhydrous glucose, 0.55 g L-cysteine, 2.0 g sodium chloride, 0.5 g sodium thioglycolate, and 0.0015 g resazurin) and cultured anaerobicly at 37°C for 24 h.
[0036] Using the domesticated second-generation FT bacterial culture, 4% was inoculated into mucin-FT induction medium (the above FT medium + 1.5 g / L porcine gastric mucin). The culture was then strictly anaerobic and statically incubated at 37°C for 24 hours, without shaking or opening the container to expose air, to obtain usable Akkermansia myxophilia for further processing.
[0037] Example 2: Aliquot the bacterial culture obtained in Example 1 into sterile centrifuge tubes and balance them. Centrifuge at 4°C, 5000×g for 10 min to completely precipitate the bacterial cells. Completely discard the supernatant (the supernatant contains free mucin, extracellular secreted proteins, and culture medium impurities, and must be completely discarded). Add sufficient pre-cooled sterile PBS to the bacterial pellet and gently resuspend it completely by pipetting. Repeat the centrifugation and washing process a total of 3 times to remove residual impurities to the greatest extent and avoid false positives in subsequent experiments.
[0038] Resuspend the bacteria thoroughly at a ratio of 1g wet bacteria to 9mL inhibitor-free lysis buffer until no visible bacterial clumps are observed.
[0039] Sonication in an ice bath (ultrasonic power: 25%–30%, operating mode: sonication for 20 seconds, interval for 30 seconds, 10 cycles); disruption criteria: the bacterial suspension changes from turbid to clear, with no obvious flocculent precipitate, and a disruption rate >80%. After disruption, centrifuge (4℃, 12000×g, centrifugation for 30 min to completely separate the intracellular supernatant from cell wall / membrane fragments). Gently aspirate the clear supernatant, which is the AKK intracellular soluble content, and discard the bottom precipitate. Filter through a 0.22μm sterile membrane to remove residual intact bacterial cells. Aliquot into small volumes, avoid repeated freeze-thaw cycles, and store at -80℃ protected from light or use immediately for subsequent experiments. The lysis buffer contains the following components: Tris-HCl 40~60mM, NaCl 140~160mM, EDTA 0.75~1.25mM, PMSF 0.8~1.2mM, MEGA-9 20~25mM (CAS: 85261-19-4). Experiment 1: Tris-HCl 50mM, NaCl 150mM, EDTA 1.0mM, PMSF 1.0mM, MEGA-9 22mM; Experiment 2: Tris-HCl 50mM, NaCl 150mM, EDTA 1.0mM, PMSF 1.0mM, MEGA-9 20mM; Experiment 3: Tris-HCl 50mM, NaCl 150mM, EDTA 1.0mM, PMSF 1.0mM, MEGA-9 25mM; Experiment 4: Tris-HCl 50mM, NaCl 150mM, EDTA 1.0mM, PMSF 1.0mM, MEGA-9 5mM; Experiment 5: Tris-HCl 50mM, NaCl 150mM, EDTA 1.0mM, PMSF 1.0mM, Triton X-100 22mM; Experiment 6: Tris-HCl 50mM, NaCl 150mM, EDTA 1.0mM, PMSF 1.0mM; The concentration of soluble protein in the supernatant was determined by the BCA method, and the yield of soluble protein was calculated using the following formula: soluble protein yield = (C × V) / W; Where C is the concentration of soluble protein in the supernatant determined by the BCA method (mg / mL), V is the volume of the recovered supernatant (mL), and W is the net weight of the wet bacteria used for extraction (g). The yield unit is mg soluble protein / g wet bacteria. Five replicates were set for each batch of samples, and the results are expressed as mean ± standard deviation.
[0040] Table 2 - Comparison of extraction efficiency of soluble protein from AKK bacteria using lysis buffers of different types and concentrations of surfactants
[0041] Table 2 shows that the extraction rates of intracellular soluble proteins for the six lysis buffer formulations ranged from 15.88% to 22.68%, with Experiment 1 showing the highest extraction rate at 22.68±1.26%, significantly higher than the other groups; Experiment 6 showed the lowest extraction rate at 15.88±1.03%. Overall, the trend was MEGA-9 series > Triton X-100 ≈ low concentration MEGA-9 > blank control, indicating that the addition of MEGA-9 had a significant promoting effect on the release of intracellular proteins from Akk bacteria.
[0042] Example 3: Fresh gastrointestinal tissue was isolated and sterilely treated to remove the mesentery and fat. The intestinal / stomach wall was longitudinally cut open, and fecal matter and mucus clumps on the surface were scraped off with sterile forceps. Sterile PBS was added, shaken for 1 minute, and the waste liquid was discarded. This process was repeated twice to remove large free contaminants.
[0043] After coarse washing, the tissue was completely immersed in the pretreatment solution at a volume ratio of 1:6; it was then treated at 37°C with shaking (50 rpm) for 12 min; the waste solution was then removed, and sterile PBS was used for shaking for 42 s, after which the waste solution was discarded. The pretreatment solution consisted of sterile PBS buffer containing 0.04 U / mL sialidase (neuraminidase), 0.03 U / mL α-L-fucosidase, 0.025 U / mL β-galactosidase, and 0.075% Tween-20.
[0044] The pretreated tissue was completely immersed in the first cleaning solution at a volume ratio of 1:4; it was then shaken at low speed (60 r / min) at 37°C for 15 min; the waste solution was then removed. The first cleaning solution contained 10 μM Zn. 2+ The formula contained 0.02% disodium EDTA, 0.0025% dispersin B, 0.002% DNase I, 0.2 mg / mL bromelain, 0.35 mg / mL intracellular extract of Akkermansia myxophilus (based on protein concentration), 0.02% L-glutamine, and 10 μM sterile PBS buffer containing Y-27632.
[0045] Completely immerse the dissociated and soaked tissue in the second washing solution at a liquid-to-material volume ratio of 1:6; shake for 1.5 min, discard the waste solution, and repeat 3 times. Then proceed to the tissue mincing and primary culture process. The second washing solution is a sterile PBS buffer containing 0.0075% benzalkonium chloride, 0.02% L-glutamine, 0.07 mg / mL of teosinte (CAS No.: 25739-41-7), and 10 μM Y-27632.
[0046] Example 4: The pretreatment solution was the same as in Example 3; the concentration of the intracellular extract of Akkermansia myxophilus in the first cleaning solution was adjusted to 0.2 mg / mL, and the other components and concentrations were the same as in Example 3; the second cleaning solution was the same as in Example 3.
[0047] Example 5: The pretreatment solution was the same as in Example 3; the concentration of the intracellular extract of Akkermansia myxophilus in the first cleaning solution was adjusted to 0.6 mg / mL, and the other components and concentrations were the same as in Example 3; the second cleaning solution was the same as in Example 3.
[0048] Example 6: The pretreatment solution was the same as in Example 3; the first cleaning solution was the same as in Example 3; the concentration of American tea catechin in the felt fibers of the second cleaning solution was adjusted to 0.05 mg / mL, and the other components and concentrations were the same as in Example 3.
[0049] Example 7: The pretreatment solution was the same as in Example 3; the first cleaning solution was the same as in Example 3; the concentration of American tea catechin in the felt fibers of the second cleaning solution was adjusted to 0.10 mg / mL, and the other components and concentrations were the same as in Example 3.
[0050] Example 8: The pretreatment solution was the same as in Example 3; the concentration of Akkermansia melanophila intracellular extract in the first cleaning solution was adjusted to 0.6 mg / mL, the concentration of bromelain was adjusted to 0.3 mg / mL, and the other components and concentrations were the same as in Example 3; the second cleaning solution was the same as in Example 3.
[0051] Comparative Example 1: The pretreatment solution was the same as in Example 3; the first cleaning solution was the same as in Example 3; no American tea extract was added to the second cleaning solution, and the remaining components and concentrations were the same as in Example 3.
[0052] Comparative Example 2: The pretreatment solution was the same as in Example 3; no intracellular extract of Akkermansia myxophilus was added to the first cleaning solution, and the remaining components and concentrations were the same as in Example 3; the second cleaning solution was the same as in Example 3.
[0053] Comparative Example 3: The pretreatment solution was the same as in Example 3; no bromelain was added to the first cleaning solution, and the remaining components and concentrations were the same as in Example 3; the remaining components and concentrations were the same as in Example 3.
[0054] Comparative Example 4: Fresh gastrointestinal tissue was isolated and sterilely treated to remove the mesentery and fat. The intestinal / stomach wall was longitudinally cut open, and fecal matter and mucus clumps on the surface were scraped off with sterile forceps. Sterile PBS was added, shaken for 1 minute, and the waste liquid was discarded. This process was repeated twice to remove large free contaminants.
[0055] The tissue block was placed in a culture dish containing sterile saline solution. Using sterile forceps, the tissue was repeatedly agitated and washed submerged for approximately 30 seconds. It was then transferred to a new culture dish containing saline solution and washed again. The turbidity of the washing solution was visually observed, and fresh saline solution was used for each wash. This process was repeated four times, with each wash lasting approximately 5 minutes. The entire procedure was performed aseptically in a laminar flow hood. After the initial wash, the tissue was completely immersed in a saline solution containing an antibiotic mixture consisting of penicillin (final concentration 150 U / mL), streptomycin (final concentration 150 μg / mL), and amphotericin B (final concentration 0.25 μg / mL). The immersion time was 10 minutes. During immersion, the tissue could be placed on a shaker and shaken at low speed (50 rpm) to ensure sufficient contact between the antibiotic solution and the tissue surface. After immersion, the tissue was removed and transferred to a new culture dish containing sterile saline solution. Agitation and washing were performed for 2 minutes to remove residual antibiotics. This rinsing process was repeated three times.
[0056] Experimental Example 1: Gastrointestinal tissues obtained from the washing of Examples 3-8 and Comparative Examples 1-3 were selected as test samples, and the number of live cells in the test samples was determined as follows.
[0057] After cleaning, the mucosal tissue was taken and minced to approximately 1 mm using sterile ophthalmic scissors. 3Tissue blocks of varying sizes were transferred to centrifuge tubes containing digestion solution (0.25% trypsin-EDTA or corresponding collagenase) at a volume ratio of 5:1 to tissue volume. The cells were digested in a 37°C shaker (90 rpm) for 30 min, with gentle pipetting every 10 min to promote cell dispersion. Once the tissue blocks had largely disappeared, an equal volume of complete culture medium containing 10% fetal bovine serum was added to terminate the digestion. The digested cell suspension was filtered through a 70 μm cell sieve to remove undigested tissue fragments and mucus clumps. The filtrate was collected and centrifuged at 300 × g for 5 min. The supernatant was discarded, and the cell pellet was resuspended in an appropriate amount of sterile PBS. After washing once, the cells were centrifuged again, and finally resuspended in 1 mL of sterile PBS to obtain the single-cell suspension for testing. Take 100 μL of single-cell suspension into a 1.5 mL microcentrifuge tube, add an equal volume of 0.4% trypan blue staining solution, gently pipette to mix, and let stand at room temperature for 2 min to stain. Take 10 μL of the stained cell suspension and inject it into the counting chamber of a hemocytometer. Place the tube under an inverted microscope and count the number of live cells in the four corner squares (top left, top right, bottom left, and bottom right) in a 20× objective lens field of view. (i.e., cells that are resisted by trypan blue, are translucent, intact, and round or oval in shape; cells stained with blue are dead cells and should not be counted.) Follow the principle of "counting the top but not the bottom, counting the left but not the right" when counting. Set up 3 parallel samples for each experimental group, count the cells separately, and take the average value. The number of live cells is calculated using the following formula: Number of live cells = (Sum of the total number of cells in the four squares ÷ 4) × 10 4 × Dilution factor × Total suspension volume (mL), where the dilution factor is 2 under the condition of equal volume mixing and staining; the results of the number of viable cells in the experimental cases of each example are shown in [reference needed]. Figure 1 .
[0058] according to Figure 1 The results of the viable cell count in Examples 3-8, compared with Comparative Examples 1-3, show the effect of different components and concentration ratios on the number of viable cells after washing. In Example 4, the concentration of the intracellular extract of *Ackermania pseudomallei* was lower than that in Example 3, but the results show that the washing effect was slightly reduced after lowering the concentration, indicating that the concentration in Example 3 was more suitable. Examples 6 and 7 verified that the number of viable cells after adding *Tea oleifera* was 4.59 ± 0.16 × 10⁻⁶. 6 4.62±0.15×10 6Example 8 increased the concentrations of *Ackermania myxophilus* intracellular extract and bromelain, but the number of viable cells decreased compared to Example 3, indicating that the substance ratios in Example 8 were not optimal. Comparative Example 1 simultaneously removed *Tetraphytin*, and the complete absence of this component reduced the number of viable cells. Comparative Examples 2 and 3 removed *Ackermania myxophilus* intracellular extract and bromelain, respectively, also resulting in a decrease in the number of viable cells. Comparative Example 4 used conventional washing methods, but the effect was significantly less than that of Example 3, with only 3.44 ± 0.24 × 10⁻⁶ viable cells. 6 In comparison, the number of live cells in Example 3 reached 5.01 ± 0.20 × 10⁶. 6 This is the best among all groups.
[0059] Experimental Example 2: Gastrointestinal tissues obtained from the washing of Examples 3-6 and Comparative Examples 1-3 were selected as test samples, and the cell viability of the obtained test samples was determined as follows.
[0060] The single-cell suspension prepared in Experiment 1 was stained with trypan blue as described above. The stained cell suspension was then injected into the counting chamber of a hemocytometer. Under a microscope, the total number of cells (all intact cells, regardless of staining) and the number of blue cells (dead cells with damaged cell membranes, blue cytoplasm, blurred boundaries, or irregular shapes) were counted in each of the four large squares. Cell debris (particles lacking intact cell shape and significantly smaller in size) was not included in the total count. Counting should be completed within 5 minutes after staining to avoid false positives caused by prolonged exposure of live cells to the stain solution. The same boundary rules as in Experiment 1 were followed during counting. Three parallel samples were used for each experimental group, and the average value was taken after counting. Cell viability was calculated using the following formula: Cell viability (%) = (Total number of cells - Number of blue cells) ÷ Total number of cells × 100%; the cell viability for each example and comparative example is shown in [link to example]. Figure 2 .
[0061] according to Figure 2 The cell viability results for Examples 3-8 were all higher than those of the comparative examples. Comparative Example 1, without the addition of catechins, had a cell viability of 72.02 ± 4.00%; Comparative Example 4, using conventional washing methods, had a cell viability of only 66.03 ± 2.00%, the lowest among the comparative examples. This result suggests that catechins have a certain protective effect on cell viability during the washing process. Among the examples, Example 3 had the highest cell viability, reaching 89.67 ± 5.03%, representing the optimal solution of this invention.
[0062] Experimental Example 3: Gastrointestinal tissues obtained from the cleaning processes of Examples 3-6 and Comparative Examples 1-3 were selected as test samples. The contamination rate of the obtained test samples was determined by culture, as detailed below.
[0063] After cleaning, the mucosal tissue was taken and trimmed into uniformly sized fragments (approximately 3mm × 3mm) using a sterile scalpel or ophthalmic scissors. The tissue fragments were evenly spread on the bottom of the culture plate, with 3 fragments per well. An appropriate amount of complete culture medium was added to just cover the surface of the tissue fragments (2.5mL per well). Each experimental group had 10 replicate wells. The culture plate was placed in a 37℃, 5% CO2 incubator for routine culture. Starting 24 hours after inoculation, the growth status of cells emanating from the tissue fragments, the morphological integrity of the tissue fragments, and the changes in the appearance of the culture medium were observed daily under an inverted microscope until 72 hours. The contamination criteria are as follows: Microscopically, numerous small rod-shaped or spherical particles exhibiting Brownian motion or clustering around the tissue block or in the culture medium, along with a noticeable yellowing and turbidity of the culture medium, indicate bacterial contamination; microscopically, filamentous hyphae, spore chains, or yeast-like budding structures, along with floating colonies on the culture medium surface, indicate fungal contamination. For suspected contamination samples that are difficult to determine under a microscope, a small amount of culture medium supernatant is taken for Gram staining to assist in confirming bacterial contamination or lactic acid cotton blue staining to confirm fungal contamination. The total number of tissue blocks in each sample group and the number of contaminated tissue blocks observed within 72 hours are recorded. The contamination rate is calculated using the following formula: Contamination rate (%) = Number of contaminated tissue blocks ÷ Total number of tissue blocks × 100%; For specific contamination rates of each example and comparative example, please refer to [link to relevant documentation]. Figure 3 .
[0064] Figure 3 The contamination rate results showed little difference among the examples, remaining relatively stable at 20-30%. Comparative Examples 2-4 had higher contamination rates, while Comparative Example 1, without the addition of *Acetobacter meliophilus* extract, had the lowest contamination rate at 51.56%. Compared to Example 3, Example 4 mainly adjusted the concentration of *Acetobacter meliophilus* intracellular extract; Examples 6 and 7 adjusted the concentration of *Acetobacter meliophilus* extract; Example 8 simultaneously increased the concentrations of both *Acetobacter meliophilus* intracellular extract and bromelain. Compared to Example 3, the contamination rates of Examples 4 to 6 were slightly higher, but overall still better than the comparative examples.
[0065] The above embodiment 3 is a preferred embodiment of the present invention, but the embodiments of the present invention are not limited to the above embodiments. Any changes, modifications, substitutions, combinations, or simplifications made without departing from the spirit and principle of the present invention shall be considered equivalent substitutions and shall be included within the protection scope of the present invention.
Claims
1. The application of intracellular extract of *Ackermania pseudomallei* in the preparation of a tissue washing solution, characterized in that, The intracellular extract was prepared by the following method: Akkermansia myxophilus was transferred and cultured sequentially on BHI and FT media 2–3 times until the OD600 reached 0.7–0.9, at which point the bacteria were harvested. The bacterial culture was then transferred to myxin-FT induction medium and cultured anaerobically. The cells were collected by centrifugation, washed with PBS, resuspended in lysis buffer containing MEGA-9, and sonicated on ice at least 10 times. The supernatant was collected by centrifugation, filtered to remove bacteria, and the supernatant was the intracellular extract, which was aliquoted and stored.
2. A tissue cleaning solution, characterized in that, Includes pretreatment solution, first cleaning solution and second cleaning solution; The pretreatment solution contains sialidase, α-L-fucosidase, β-galactosidase and Tween-20; The first washing solution is a sterile PBS buffer containing intracellular extract of Akkermansia muciniphila and bromelain, wherein the mass ratio of the intracellular extract to bromelain is 1 to 3:1, and the total content of the two is 0.4 mg / mL to 1.2 mg / mL. The second washing solution contains sterile PBS buffer containing catechins from the fusiforme, wherein the catechins from the fusiforme contain 0.05 mg / mL to 0.1 mg / mL.
3. A method for using an isolated tissue cleaning solution, characterized in that, Includes the following steps: (1) Take fresh tissue from the body, remove the mesentery and / or fat under aseptic conditions, cut the tissue wall longitudinally, scrape off the surface dirt with sterile forceps; add sterile PBS, shake and discard the waste liquid; (2) The tissue after coarse washing is completely immersed in the pretreatment solution described in claim 2, shaken at 37°C, then the waste liquid is removed, sterile PBS is added and shaken for 0.5 to 1 min, and then the waste liquid is discarded. (3) The pretreated tissue is completely immersed in the first cleaning solution described in claim 2, and shaken at a low speed at 37°C, and then the waste liquid is removed; (4) The tissue after the first cleaning is completely immersed in the second cleaning solution described in claim 2, and the waste liquid is discarded after shaking treatment. The immersion and shaking operation is repeated 3 to 5 times to obtain the cleaned isolated gastrointestinal tissue.
4. The method of use according to claim 3, characterized in that, In step (2), the volume ratio of the tissue to the pretreatment liquid is 1:5 to 8, the oscillation speed is 40 r / min to 60 r / min, and the treatment time is 10 to 15 min.
5. The method of use according to claim 3, characterized in that, In step (3), the volume ratio of the tissue to the first cleaning solution is 1:3 to 5, the oscillation speed is 50 r / min to 80 r / min, and the processing time is 10 to 20 min.
6. The method of use according to claim 3, characterized in that, In step (4), the volume ratio of the tissue to the second cleaning solution is 1:5 to 8, the oscillation speed is 50 r / min to 80 r / min, and the processing time for each treatment is 1 to 2 min.
7. The use of the tissue cleaning solution according to claim 2 in the preparation of reagents or kits for cleaning ex vivo tissues.
8. The application of the method of use according to any one of claims 3 to 6 in the cleaning of isolated tissues, characterized in that, The ex vivo tissue was selected from the mucosa of the stomach, small intestine, colon, rectum, bile duct, or esophagus.
